“Cancer Immunotherapy Treatment Shows More Promise,”

A technique to genetically modify a patient`s own immune cells eradicated tumors in 14 of 16 patients with advanced leukemia-at least for a time-in a study that adds to growing enthusiasm for efforts to enlist the body`s immune system in the fight against cancer. The findings, from researchers at Memorial Sloan-Kettering Cancer Center, also add fuel to an emerging race to bring new so-called cancer immunotherapy treatments to the market. Juno Therapeutics Inc., a Seattle startup, is preparing t...
Source: National Comprehensive Cancer Network - Category: Cancer & Oncology Source Type: news